
Identification panel for 23 RBC antigens by DNA analysis.
Routine genetic identification of the most clinically relevant blood group variants related to transfusional compatibility is a widely-used practice. Early and precise identification of genetic variants reduces the likelihood of alloantibody formation, facilitating blood matching in subsequent transfusions.